Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities
Genetics
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities

14, Feb 2026

2
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities
Genetics
Genetic Architecture of Intrathecal IgG Synthesis in Multiple Sclerosis: Integrating GWAS Signals, HLA Haplotypes, and Polygenic Risk

13, Feb 2026

3
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy
Genetics
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy

12, Feb 2026

4
Polygenic Risk Scores and Lifetime Multiple Sclerosis Risk: Translating Genetic Susceptibility Into Absolute Probability
Genetics
Polygenic Risk Scores and Lifetime Multiple Sclerosis Risk: Translating Genetic Susceptibility Into Absolute Probability

12, Feb 2026

5
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program
Genetics
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program

11, Feb 2026

Categories:
Genetics
Genetic Discovery in Rare Diseases: Uncovering the Underlying Genetic Etiologies of 269 Disorders
Genetics
Genetic Discovery in Rare Diseases: Uncovering the Underlying Genetic Etiologies of 269 Disorders

14, Nov 2024

Natural Killer Cells in Multiple Sclerosis: A New Frontier in Immune Research
Genetics
Natural Killer Cells in Multiple Sclerosis: A New Frontier in Immune Research

15, Nov 2024

Charting the Genetic Background of Multiple Sclerosis: Landmark GWAS Insights
Genetics
Charting the Genetic Background of Multiple Sclerosis: Landmark GWAS Insights

16, Nov 2024

Bruton Tyrosine Kinase Inhibitors: A New Frontier in Multiple Sclerosis Treatment
Genetics
Bruton Tyrosine Kinase Inhibitors: A New Frontier in Multiple Sclerosis Treatment

18, Nov 2024